US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist
  • 1.030
  • +0.030+3.04%
Close Apr 30 16:00 ET
  • 1.000
  • -0.030-2.95%
Post 20:01 ET
119.40MMarket Cap4.12P/E (TTM)

Coherus BioSciences Key Stats

Coherus BioSciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 12.104M--
--2025/Q1-- / 60.964M--
Mar 10, 20252024/Q454.144M / 43.877M--
Nov 6, 20242024/Q370.774M / 56.806M--
Aug 8, 20242024/Q264.979M / 56.423M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 12.104M--
--2025/Q1-- / 60.964M--
Mar 10, 20252024/Q454.144M / 43.877M--
Nov 6, 20242024/Q370.774M / 56.806M--
Aug 8, 20242024/Q264.979M / 56.423M--

Unlock Free Earnings Estimates

Coherus BioSciences Earnings Reports

Read more

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More